Related references
Note: Only part of the references are listed.Clinical and Biological Significance of Hepsin Overexpression in Breast Cancer
Peng Xing et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
The Membrane-anchored Serine Protease Prostasin (CAP1/PRSS8) Supports Epidermal Development and Postnatal Homeostasis Independent of Its Enzymatic Activity
Diane E. Peters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity
David J. Marchant et al.
NATURE MEDICINE (2014)
Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis
Xi Tang et al.
ONCOTARGET (2014)
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
V. Heinemann et al.
BRITISH JOURNAL OF CANCER (2013)
A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features PROSTASIN AS A NON-ENZYMATIC CO-FACTOR FOR MATRIPTASE ACTIVATION
Stine Friis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Prostasin Is Required for Matriptase Activation in Intestinal Epithelial Cells to Regulate Closure of the Paracellular Pathway
Marguerite S. Buzza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4
Johanna I. Partanen et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors
Rajeev Goswami et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Allosteric antibody inhibition of human hepsin protease
Tobias Koschubs et al.
BIOCHEMICAL JOURNAL (2012)
Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase
Takahiro Domoto et al.
CANCER SCIENCE (2012)
Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice
Yu-Chen Hsu et al.
HEPATOLOGY (2012)
Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity
Johanna I. Partanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An allosteric anti-hepsin antibody derived from a constrained phage display library
Rajkumar Ganesan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Role of Integrins in Regulating Proteases to Mediate Extracellular Matrix Remodeling
Jiao Yue et al.
CANCER MICROENVIRONMENT (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Proteolytic Activation of Pro-Macrophage-Stimulating Protein by Hepsin
Rajkumar Ganesan et al.
MOLECULAR CANCER RESEARCH (2011)
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
Kristen L. Meerbrey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment
Toni M. Antalis et al.
BIOCHEMICAL JOURNAL (2010)
Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation
Ya-Wen Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor
Mengqian Chen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
The Met oncogene and basal-like breast cancer: another culprit to watch out for?
Stefania Gastaldi et al.
BREAST CANCER RESEARCH (2010)
Pegylated Kunitz Domain Inhibitor Suppresses Hepsin-Mediated Invasive Tumor Growth and Metastasis
Wei Li et al.
CANCER RESEARCH (2009)
Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary
Sine Godiksen et al.
BIOCHEMICAL JOURNAL (2008)
Type II transmembrane serine proteases in development and disease
Roman Szabo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model
Jiangyong Miao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression
Manisha Tripathi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Identification and characterization of small-molecule inhibitors of hepsin
John R. Chevillet et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization
Johanna I. Partanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development
R. Szabo et al.
ONCOGENE (2007)
Pro-urokinase-type plasminogen activator is a substrate for hepsin
Paul Moran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
Ken-ichi Kiyomiya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Proteomic analysis of hen egg white
Catherine Guerin-Dubiard et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture
JA Xuan et al.
CANCER RESEARCH (2006)
Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin
B Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
S Herter et al.
BIOCHEMICAL JOURNAL (2005)
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation
K List et al.
GENES & DEVELOPMENT (2005)
Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2
D Kirchhofer et al.
FEBS LETTERS (2005)
Identification and characterization of hepsin/-TM, a non-transmembrane hepsin isoform
Y Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2005)
Hepsin promotes prostate cancer progression and metastasis
O Klezovitch et al.
CANCER CELL (2004)
The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain
JR Somoza et al.
STRUCTURE (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Scatter-factor and semaphorin receptors: Cell signalling for invasive growth
L Trusolino et al.
NATURE REVIEWS CANCER (2002)
Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor
C Benaud et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Share Paper
